MedPath

Indiana University School Of Medicine

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
1903-01-01
Employees
-
Market Cap
-
Website
http://www.medicine.iu.edu

Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial

Not Applicable
Terminated
Conditions
Cesarean Section
Endometritis
Surgical Wound Infection
Interventions
Procedure: Vaginal cleansing before cesarean delivery
First Posted Date
2006-10-11
Last Posted Date
2010-02-08
Lead Sponsor
Indiana University School of Medicine
Target Recruit Count
300
Registration Number
NCT00386477
Locations
πŸ‡ΊπŸ‡Έ

Methodist Hospital, Indianapolis, Indiana, United States

πŸ‡ΊπŸ‡Έ

University Hospital, Indianapolis, Indiana, United States

πŸ‡ΊπŸ‡Έ

Wishard Memorial Hospital, Indianapolis, Indiana, United States

Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes

Not Applicable
Withdrawn
Conditions
Exercise-Induced Bronchospasm
First Posted Date
2006-09-12
Last Posted Date
2016-01-07
Lead Sponsor
Indiana University School of Medicine
Registration Number
NCT00375232
Locations
πŸ‡ΊπŸ‡Έ

National Institue Of Fitness and Sport, Indianapolis, Indiana, United States

Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer

Phase 1
Completed
Conditions
Pancreatic Cancer
Adenocarcinoma of the Pancreas
Interventions
Drug: Gemcitabine, Sorafenib
Procedure: Radiotherapy
First Posted Date
2006-09-12
Last Posted Date
2016-02-29
Lead Sponsor
Indiana University School of Medicine
Target Recruit Count
27
Registration Number
NCT00375310
Locations
πŸ‡ΊπŸ‡Έ

Indiana University Simon Cancer Center, Indianapolis, Indiana, United States

Extending HIV Care Beyond the Rural Health Center

Not Applicable
Completed
Conditions
HIV
HIV Infections
Interventions
Other: Home visit by community care coordinators
First Posted Date
2006-09-04
Last Posted Date
2016-12-20
Lead Sponsor
Indiana University School of Medicine
Target Recruit Count
208
Registration Number
NCT00371540
Locations
πŸ‡°πŸ‡ͺ

Mosoriot Rural Health Center, Mosoriot, Kenya

A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

Phase 2
Completed
Conditions
Thymic Cancer
Thymoma
First Posted Date
2006-08-30
Last Posted Date
2014-06-03
Lead Sponsor
Indiana University School of Medicine
Target Recruit Count
18
Registration Number
NCT00369889
Locations
πŸ‡ΊπŸ‡Έ

Indiana University Cancer Center, Indianapolis, Indiana, United States

Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children

Phase 4
Terminated
Conditions
Infection Prevention
Interventions
Device: Non-impregnated Catheters (C/S)
Device: Antibiotic-impregnated Catheters (M/R)
First Posted Date
2006-08-30
Last Posted Date
2016-02-24
Lead Sponsor
Indiana University School of Medicine
Target Recruit Count
326
Registration Number
NCT00370149
Locations
πŸ‡ΊπŸ‡Έ

Riley Hospital for Children, Indianapolis, Indiana, United States

Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.

Phase 4
Completed
Conditions
Cataract
First Posted Date
2006-07-24
Last Posted Date
2007-10-17
Lead Sponsor
Indiana University School of Medicine
Target Recruit Count
48
Registration Number
NCT00355446
Locations
πŸ‡ΊπŸ‡Έ

University Hospital, Indianapolis, Indiana, United States

πŸ‡ΊπŸ‡Έ

Veterans Affairs Medical Center, Indianapolis, Indiana, United States

πŸ‡ΊπŸ‡Έ

Wishard Memorial Hospital, Indianapolis, Indiana, United States

and more 1 locations

Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer

Terminated
Conditions
Breast Cancer
First Posted Date
2006-07-17
Last Posted Date
2018-03-02
Lead Sponsor
Indiana University School of Medicine
Target Recruit Count
23
Registration Number
NCT00352872
Locations
πŸ‡ΊπŸ‡Έ

Indiana University Cancer Center, Indianapolis, Indiana, United States

Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients

Not Applicable
Completed
Conditions
Cataract
First Posted Date
2006-07-17
Last Posted Date
2007-10-17
Lead Sponsor
Indiana University School of Medicine
Target Recruit Count
22
Registration Number
NCT00352807
Locations
πŸ‡ΊπŸ‡Έ

University Hospital, Indianapolis, Indiana, United States

πŸ‡ΊπŸ‡Έ

Wishard Memorial Hospital, Indianapolis, Indiana, United States

πŸ‡ΊπŸ‡Έ

Iu Eye at Carmel, Indianapolis, Indiana, United States

and more 1 locations

Study to Determine Effective Dosing of Fondaparinux in Obese Persons

Phase 1
Withdrawn
Conditions
Morbid Obesity
First Posted Date
2006-06-30
Last Posted Date
2016-02-23
Lead Sponsor
Indiana University School of Medicine
Registration Number
NCT00346879
Locations
πŸ‡ΊπŸ‡Έ

Clarian Bariatric Center, Indianapolis, Indiana, United States

Β© Copyright 2025. All Rights Reserved by MedPath